Quốc gia: Israel
Ngôn ngữ: Tiếng Anh
Nguồn: Ministry of Health
DEXAMETHASONE PHOSPHATE (AS SODIUM)
PHARMALOGIC LTD
R01AD03
SOLUTION FOR INJECTION / INFUSION
DEXAMETHASONE PHOSPHATE (AS SODIUM) 4 MG / 1 ML
I.M, I.V
Required
PANPHARMA, FRANCE
DEXAMETHASONE
Dexamethasone Panpharma is indicated in the treatment ofEndocrine diseases such as nonsuppurative thyroiditis, hypercalcaemia associated with cancer and congenital adrenal hyperplasia.Allergy: Severe or disabling allergic conditions resistant to conventional treatments, as in: bronchial asthma, contact or atopical dermatitis, seasonal or perennial allergic rhinitis, hypersensitivity reactions to drugs. Ophtalmic: Serious inflammatory and allergic processes, acute and chronic, affecting the eyes, such as: iritis and iridocyclitis, chorioretinitis, choroiditis and diffuse posterior uveitis, optical neuritis, allergic conjunctivitis, allergic marginal corneal ulcers. Inflammatory Bowel dis.: Systemic treatment in exacerbations of ulcerative colitis and regional enteritis. Dermatological diseases (pemphigus, Stevens Johnson syndrome, exfoliative dermatitis, severe psoriasis and mycosis fungoides) Respiratory diseases (symptomatic sarcoidosis, berylliosis, Loeffler's syndrome) Haematological: acquired )autoimmune( haemolytic anaemia, idiopathic thrombocytopenic purpura in adult, pure red cell aplasia Nephrotic syndrome of the idiopathic type or that due to lupus erythematosus Cerebral oedema caused by brain tumor, neurosurgery, brain abscess, bacterial meningitis Collagen diseases: Active rheumatoid arthritis with severe progressive course, fast destructive remitting forms and / or extra-articular manifestations, Juvenile idiopathic arthritis with severe systemic-onset form (Still's disease) or locally with no control, rheumatic fever with carditis, dermatomyositis, polymyositis, SLE, temporal arteritis. Infectious Diseases: Bacterial meningitis – adjunct to antibiotics in suspected Pneumococcal meningitis and TB meningitis. Severe infectious diseases with toxic states (eg tuberculosis, typhoid, brucellosis;. Only with simultaneous anti-infective therapy) Fetal lung maturation Chemotherapy – associated nausea and vomiting Multiple Myeloma – part of chemotherapy protocols (eg VAD) Prevention and treatment of acute mountain sickness/HACE
2021-04-04
1 1. NAME OF THE MEDICINAL PRODUCT Dexamethasone Panpharma 4 mg/ml 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution contains 3.3 mg dexamethasone (as sodium phosphate) which is equivalent to 4 mg dexamethasone phosphate or 4.37 mg dexamethasone sodium phosphate. It contains 0.4 mg/ 1 ml of Sodium per ampoule. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection / Infusion 4. CLINICAL PARTICULARS 4.1. THERAPEUTIC INDICATIONS By intramuscular or intravenous route Dexamethasone Panpharma is indicated in the treatment of: • Endocrine diseases such as nonsuppurative thyroiditis, hypercalcaemia associated with cancer and congenital adrenal hyperplasia. • Allergy: Severe or disabling allergic conditions resistant to conventional treatments, as in: bronchial asthma, contact or atopical dermatitis, seasonal or perennial allergic rhinitis, hypersensitivity reactions to drugs. • Ophtalmic: Serious inflammatory and allergic processes, acute and chronic, affecting the eyes, such as: iritis and iridocyclitis, chorioretinitis, choroiditis and diffuse posterior uveitis, optical neuritis, allergic conjunctivitis, allergic marginal corneal ulcers. • Inflammatory Bowel dis.: Systemic treatment in exacerbations of ulcerative colitis and regional enteritis. • Dermatological diseases (pemphigus, Stevens Johnson syndrome, exfoliative dermatitis, severe psoriasis and mycosis fungoides) • Respiratory diseases (symptomatic sarcoidosis, berylliosis, Loeffler's syndrome) • Haematological: acquired )autoimmune( haemolytic anaemia, idiopathic thrombocytopenic purpura in adult, pure red cell aplasia • Nephrotic syndrome of the idioplathic type or that due to lupus erythematosus • Cerebral edema caused by brain tumor, neurosurgery, brain abscess, bacterial meningitis • Collagen diseases: Active rheumatoid arthritis with severe progressive course, fast destructive remitting forms and / or extra-articular manifestations, Juvenile idiopathic arthritis with severe systemi Đọc toàn bộ tài liệu